Savant Capital’s Veracyte VCYT Stock Holding History

Savant Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,578	Closed	-$260K	–	1421
2024 Q4	$260K	Buy	6,578 +37	+0.6%	+$1.4K	﹤0.01%	1186
2024 Q3	$223K	Buy	+6,541	New	+$184K	﹤0.01%	1232

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Savant Capital's VCYT Position: Q1 2025 in Review

Savant Capital sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 6,578 shares — an estimated $260K sold.

Savant Capital first reported a position in VCYT in Q3 2024 and held it in 2 quarters. The position peaked at $260K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

Savant Capital reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
Savant Capital sold 6,578 Veracyte shares in Q1 2025, an estimated $260K.
Savant Capital first reported a position in Veracyte in Q3 2024 and held it in 2 quarters.
Savant Capital's Veracyte position peaked at $260K in Q4 2024.
287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Savant Capital's 13F filing for Q1 2025, filed 8 May 2025.